-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QYKKnaEGilAYhjPi2SOnhu+fW9i1wXYzQOWMp17osQ62WZPZElDPL6JYm2QhCZQm EU80GTd1zZv9LXDxStpaZA== 0001144204-03-001850.txt : 20030417 0001144204-03-001850.hdr.sgml : 20030417 20030417162658 ACCESSION NUMBER: 0001144204-03-001850 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030417 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TECH LABORATORIES INC CENTRAL INDEX KEY: 0000096664 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] IRS NUMBER: 221436279 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-58503 FILM NUMBER: 03654523 BUSINESS ADDRESS: STREET 1: 955 BELMONT AVE CITY: NORTH HALEDON STATE: NJ ZIP: 07508 BUSINESS PHONE: 9734275333 MAIL ADDRESS: STREET 1: TECH LABORATORIES INC STREET 2: 955 BELMONT AVE CITY: NORTH HALEDON STATE: NJ ZIP: 07508 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CIONGOLI BERNARD M CENTRAL INDEX KEY: 0001106986 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 955 BELMONT AVENUE CITY: NORTH HALEDON STATE: NJ ZIP: 07508 BUSINESS PHONE: 9734275333 MAIL ADDRESS: STREET 1: 17 LIBERTY RIDGE TRAIL CITY: TOTOWA STATE: NJ ZIP: 07512 SC 13D 1 doc1.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A (RULE 13D-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13D-1(A) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(A) Tech Laboratories, Inc. (NAME OF ISSUER) COMMON STOCK, $0.01 PAR VALUE PER SHARE (TITLE OF CLASS OF SECURITIES) 878249101 (CUSIP NUMBER) Craig H. Effrain Stursberg & Veith 405 Lexington Avenue, Suite 4949 Mew York, New York 10174 212-922-1177 (NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICES AND COMMUNICATIONS) (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) February 1, 2003 & January 30, 2003 (vesting of options) IF THE FILING PERSON HAS PREVIOUSLY FILED A STATEMENT ON SCHEDULE 13G TO REPORT THE ACQUISITION WHICH IS THE SUBJECT OF THIS SCHEDULE 13D, AND IS FILING THIS SCHEDULE BECAUSE OF RULE 13D-1(E), 13D-1(F) OR 13D-1(G), CHECK THE FOLLOWING BOX / /. NOTE: SCHEDULES FILED IN PAPER FORMAT SHALL INCLUDE A SIGNED ORIGINAL AND FIVE COPIES OF THE SCHEDULE, INCLUDING ALL EXHIBITS. SEE RULE 13D-7 FOR OTHER PARTIES TO WHOM COPIES ARE TO BE SENT. * THE REMAINDER OF THIS COVER PAGE SHALL BE FILLED OUT FOR A REPORTING PERSON'S INITIAL FILING ON THIS FORM WITH RESPECT TO THE SUBJECT CLASS OF SECURITIES, AND FOR ANY SUBSEQUENT AMENDMENT CONTAINING INFORMATION WHICH WOULD ALTER DISCLOSURES PROVIDED IN A PRIOR COVER PAGE. THE INFORMATION REQUIRED ON THE REMAINDER OF THIS COVER PAGE SHALL NOT BE DEEMED TO BE "FILED" FOR THE PURPOSE OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934 ("ACT") OR OTHERWISE SUBJECT TO THE LIABILITIES OF THAT SECTION OF THE ACT BUT SHALL BE SUBJECT TO ALL OTHER PROVISIONS OF THE ACT (HOWEVER, SEE THE NOTES). SCHEDULE 13D CUSIP NO - --------------------------------------------------------------------- (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Bernard M. Ciongoli, ###-##-#### - --------------------------------------------------------------------- (2) CHECK THE APPROPRIATE BOX IF A (A) / / MEMBER OF A GROUP (SEE INSTRUCTIONS) (B) / / - --------------------------------------------------------------------- (3) SEC USE ONLY - --------------------------------------------------------------------- (4) SOURCE OF FUNDS (SEE INSTRUCTIONS) 00 This Schedule is being filed pursuant to the vesting of certain options previously granted to Mr. Ciongoli. - --------------------------------------------------------------------- (5) CHECK BOX IF DISCLOSURE OF LEGAL / / PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) - --------------------------------------------------------------------- (6) CITIZENSHIP OR PLACE OF ORGANIZATION USA - --------------------------------------------------------------------- NUMBER OF SHARES (7) SOLE VOTING POWER BENEFICIALLY OWNED BY EACH 1,423,666 REPORTING PERSON ---------------------------------------------- WITH (8) SHARED VOTING POWER 0 ---------------------------------------------- (9) SOLE DISPOSITIVE POWER 1,423,666 ---------------------------------------------- (10) SHARED DISPOSITIVE POWER 0 - --------------------------------------------------------------------- (11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,423,666 - --------------------------------------------------------------------- (12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) / EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) - --------------------------------------------------------------------- (13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 22.15% - --------------------------------------------------------------------- (14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - --------------------------------------------------------------------- ITEM 1. SECURITY AND ISSUER. This Schedule relates to the Common Stock, par value $.01 per share, of Tech Laboratories, Inc., 955 Belmont Ave., North Haledon, NJ 07508. ITEM 2. IDENTITY AND BACKGROUND. Bernard M. Ciongoli Tech Laboratories, Inc. 955 Belmont Avenue North Haledon, NJ 07508 Mr. Ciongoli is the president of Tech Laboratories, Inc. None None USA ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. This Schedule is being filed pursuant to the vesting of options previously granted to Mr. Ciongoli. ITEM 4. PURPOSE OF TRANSACTION. See Item 3. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. See Items 7 through 13 of the cover page of this Schedule. As of the date of this Schedule, Mr. Ciongoli beneficially owned 1,423,666 shares, which includes 100,000 immediately exercisable options at $.9625 per share, 300,000 immediately exercisable options at $.50 per share, 300,000 immediately exercisable options at $.43 per share, 111,000 immediately exercisable options at $2.68125 per share, and 92,666 immediately exercisable options at $2.4375 per share. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS, OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. None. ITEM 7. MATERIALS TO BE FILED AS EXHIBITS. None. SIGNATURE AFTER REASONABLE INQUIRY AND TO THE BEST OF MY KNOWLEDGE AND BELIEF, I CERTIFY THAT THE INFORMATION SET FORTH IN THIS STATEMENT IS TRUE, COMPLETE AND CORRECT. DATED: April 17, 2003 /S/ Bernard M. Ciongoli ------------------------ Bernard M. Ciongoli President, Tech Laboratories, Inc. -----END PRIVACY-ENHANCED MESSAGE-----